Search

9 May 2022: Hybridoma cell line producing YTH 906.9HL antibodies raised against human CD25 which are rat monoclonal antibodies of the IgG2b isotype.

4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard

9 May 2022: JBIG-KIT software library is an implementation of the JBIG1 data compression standard (ITU-T T.82), which was designed for bi-level high-resolution image data.

20 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 20 September 2022. Cambridge Enterprise, Cambridge Innovation Capital, and University launch Innovate Cambridge. Share:. Cambridge Enterprise, Cambridge Innovation Capital, and the

9 May 2022: Hybridoma cell line producing YW 62.3.20 antibodies raised against mouse CD45 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTA 74.4.4 antibodies raised against mouse CD71 which are monoclonal antibodies of the IgG2a isotype.

8 Dec 2022: Innovate Cambridge’s founders, new steering committee and charter signatories will now begin to define an ambitious, inclusive vision for the greater Cambridge area. ... A constant source of new ideas and innovations, the Cambridge innovation ecosystem

9 May 2022: KARPAS 1718 Human Splenic Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158F allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.

9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158V allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.

9 May 2022: Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are rat monoclonal antibodies of the IgG2a isotype.

9 May 2022: Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mouse monoclonal antibodies.

9 May 2022: KARPAS 45 Human T-cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: KARPAS 353 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: KARPAS 231 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YBM 29.2.1antibodies raised against mouse Thy-1, which are rat monoclonal antibodies of the IgG2c isotype.

9 May 2022: Sharp graphite tips have been developed in the lab of Dr Amalio Fernandez-Pacheco at the University of Cambridge using a three-step polishing method.

9 May 2022: Tetrabutylammonium (4'methyl-[2,2'bipyridin]-5yl)methanesulfonate is a ligand for iridium to control regioselectivity of iridium-catalysed borylation

9 May 2022: Hybridoma cell line producing SIg 375 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 482 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 743 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YTH 862.2 antibodies raised against human HLA-class I which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR CT-1 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 83-7 antibodies raised against the human insulin receptor, which are mouse monoclonal antibodies of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR CT-3 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 47-9 antibodies raised against the alpha subunit of the human insulin receptor,which are monoclonals of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-45 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-43 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 18-42 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 83-14 antibodies against the alpha subunit of the human insulin receptor, which are mouse monoclonals of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 83-12 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-44 antibodies raised against beta subunit of the human insulin receptor which are mouse monoclonals of IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 25-49 antibodies raised against the alpha subunit of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-34 antibodies raised against the extracellular domain of the human insulin receptor which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 83-22 antibodies raised against the alpha subunit of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-40 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing YTS 154.7.7.10 antibodies raised against mouse Thy-1 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 18-146 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing YTS 121.5.2 antibodies raised against mouse CD5 (lyt-1) which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTS 156.7.7 antibodies raised against mouse CD8 (lyt-3) which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTS 105.18.10 antibodies raised against mouse CD8 (lyt-2) which are rat monoclonal antibodies of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing YTA 3.1.2 antibodies raised against mouse CD4 Epitope B which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTS 191.1.2 antibodies raised against mouse CD4 epitope A which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTS 169.4.2.1 antibodies raised against mouse CD8 (lyt-2), which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YTH470.5 antibodies raised against human beta 2-microglobulin which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: University of Cambridge scientists has developed a neural network method that can predict the solubility of a protein from the amino acid sequence

9 May 2022: KARPAS 422 Human B-cell Non-Hodgkin's Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: KARPAS 384 Human T-cell non-Hodgkin's Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YBM 5.10.4 antibodies raised against mouse heat stable antigen which are rat monoclonal antibodies of the IgG2c isotype.